Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial

Autor:	Mauz-Körholz, Christine *, Landman-Parker, Judith *, Balwierz, Walentyna *, Ammann, Roland A, Anderson, Richard A, Attarbaschi, Andische, Bartelt, Jörg M, Beishuizen, Auke, Boudjemaa, Sabah, Cepelova, Michaela, Claviez, Alexander, Daw, Stephen, Dieckmann, Karin, Fernández-Teijeiro, Ana, Fosså, Alexander, Gattenlöhner, Stefan, Georgi, Thomas, Hjalgrim, Lisa L, Hraskova, Andrea, Karlén, Jonas, Kluge, Regine, Kurch, Lars, Leblanc, Thiery, Mann, Georg, Montravers, Francoise, Pears, Jean, Pelz, Tanja, Rajić, Vladan, Ramsay, Alan D, Stoevesandt, Dietrich, Uyttebroeck, Anne, Vordermark, Dirk, Körholz, Dieter, Hasenclever, Dirk, Wallace, William Hamish *
Zdroj:	In The Lancet Oncology January 2022 23(1):125-137
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu